Match the claim to the study type. Cell and tissue work describes what happens in a controlled preparation, animal models describe what happens in a living organism that is not a person, and randomized human trials describe measured outcomes in a defined population. Most overstated peptide claims come from quietly promoting a finding one or two tiers above its source.
Three tiers, three kinds of sentence
| Cell and tissue | Supports: “in this preparation, the measured signal changed.” Does not support statements about people. |
|---|---|
| Animal model | Supports: “in this species and model, this outcome was observed.” Species, model and timing all constrain the reading. |
| Randomized human trial | Supports: “in this population, over this period, the measured endpoint differed from the comparator.” |
Worked example: tissue-level work
A 2011 study of rat Achilles tendon-derived explants and cells reported increased outgrowth, better cell survival under stress and increased migration with BPC-157, and examined FAK and paxillin phosphorylation; direct increases in proliferation were not reported. [Chang et al., 2011]
That is a mechanistic observation in tissue from one species. The honest sentence is about explants and cells. Rewriting it as tendon healing or pain relief in people adds a population, an outcome and a duration that the experiment never contained.
Worked example: animal models
Work on thymosin beta-4 and a synthetic peptide containing its actin-binding domain reported promotion of dermal wound repair in diabetic and aged mice. [Philp et al., 2003]
Animal models sit closer to a whole-organism outcome than cell work, but the model is chosen precisely because it is a simplified stand-in. Impaired-healing mouse models are informative about the model; they are not clinical proof.
Worked example: randomized human trials
Human trial reports state their population and duration explicitly — for instance a 48-week phase 2 trial of retatrutide in 338 adults, or a 26-week trial of tesamorelin in 412 patients with HIV and abdominal fat accumulation. Both reported measured outcomes together with adverse effects, including gastrointestinal events and heart-rate increases in the retatrutide report and more withdrawals due to adverse events in the tesamorelin report. [Jastreboff et al., 2023][Falutz et al., 2007]
A checklist you can apply in a minute
- Identify the study type before reading the conclusion.
- Write down the species or population, and the duration.
- Note the comparator: placebo, active control, or none.
- Ask whether the endpoint is the outcome anyone actually cares about.
- Check whether harms were reported alongside benefits.
- State the finding in the narrowest sentence the source supports.